MassMutual Private Wealth & Trust’s GSK GSK Stock Holding History

MassMutual Private Wealth & Trust’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-1,214	Closed	-$61.6K	–	938
2017 Q3	$61.6K	Buy	1,214 +288	+31%	+$14.6K	0.01%	482
2017 Q2	$49.9K	Sell	926 -555	-37%	-$29.6K	﹤0.01%	482
2017 Q1	$78K	Buy	1,481 +920	+164%	+$46.7K	0.01%	414
2016 Q4	$27K	Buy	+561	New	+$27.7K	﹤0.01%	400
2016 Q2	$123K	Buy	2,272 +2,093	+1,169%	+$110K	0.02%	343
2016 Q1	$9.08K	Sell	179 -52	-23%	-$2.59K	﹤0.01%	549
2015 Q4	$11.7K	Sell	231 -1,227	-84%	-$62.5K	﹤0.01%	467
2015 Q3	$83.8K	Buy	1,458 +801	+122%	+$41.7K	0.02%	340
2015 Q2	$43.9K	Buy	657 +499	+316%	+$28.1K	0.01%	369
2015 Q1	$9.14K	Sell	158 -40	-20%	-$2.29K	﹤0.01%	514
2014 Q4	$10.6K	Sell	198 -1,260	-86%	-$70.5K	﹤0.01%	405
2014 Q3	$83.8K	Buy	1,458 +1,184	+432%	+$72.6K	0.02%	330
2014 Q2	$18.3K	Hold	274	–	–	0.01%	306
2014 Q1	$18.3K	Buy	+274	New	+$18.5K	0.01%	273

Other funds holding GSK

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

MassMutual Private Wealth & Trust's GSK Position: Q4 2017 in Review

MassMutual Private Wealth & Trust sold out of GSK (GSK) in Q4 2017, closing a stake of 1,214 shares — an estimated $61.6K sold.

MassMutual Private Wealth & Trust first reported a position in GSK in Q1 2014 and held it in 14 quarters. The position peaked at $123K in Q2 2016. 763 funds tracked by Wall St. Rank hold GSK as of Q4 2017.

MassMutual Private Wealth & Trust reported no remaining GSK position as of Q4 2017 after selling out during the quarter.
MassMutual Private Wealth & Trust sold 1,214 GSK shares in Q4 2017, an estimated $61.6K.
MassMutual Private Wealth & Trust first reported a position in GSK in Q1 2014 and held it in 14 quarters.
MassMutual Private Wealth & Trust's GSK position peaked at $123K in Q2 2016.
763 funds tracked by Wall St. Rank held GSK as of Q4 2017.

Based on MassMutual Private Wealth & Trust's 13F filing for Q4 2017, filed 21 Feb 2018.